NEW

FDA Updates Information on Respirator Decontamination Systems

The U.S. Food and Drug Administration (FDA) is reissuing the Emergency Use Authorizations for decontamination systems that are authorized to decontaminate compatible N95 respirators for use by healthcare personnel (HCP) to prevent exposure to pathogenic biological...

First Patient Treated in Clinical Trial of BCL System

CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise, announced that the first patient has been treated in its U.S. pivotal trial of the Breast Cancer Locator (BCL) System at Massachusetts General Hospital.

Rush Oak Park Hospital Adopts Surgical Workflow Technology, ExplORer Surgical, Increasing Team Confidence and Reducing OR Challenges

ExplORer Surgical, the only comprehensive intraoperative case support and workflow platform, has reinvented the way surgical support teams prepare and complete effective surgeries with two-way video for case support and remote proctoring to create a digitized playbook.

AORN Releases 2021 Guidelines for Perioperative Practice

The Association of periOperative Registered Nurses (AORN) has published the 2021 Guidelines for Perioperative Practice with six revised guidelines.

Aspen Medical Announces New President & CEO

Aspen Medical ProductsAspen Medical Products, LLC is excited to announce the appointment of seasoned orthopedic and spine executive, Jim Cloar, as the new President and CEO of Aspen Medical Products. Cloar will be succeeding Dan Williamson, founder of Aspen Medical Products, who will continue to be involved as a member of the Company’s Board of Directors and as a meaningful shareholder. Cloar comes with a rich background leading growth and expansion in orthopedic organizations focused on spine including DePuy, Medtronic, Biomet, and most recently, as President, Global Spine for ZimmerBiomet.

“I see Aspen Medical Products as the leader in spinal bracing products both within the US, and internationally, and welcome the opportunity to take this dynamic company from its history of innovation, quality and customer-focused product delivery to the next level of its evolution of growth and success,” Cloar stated upon accepting the position. “With the seasoned and dynamic executive team, well respected direct sales group, stellar relationships with key distributors, a culture of inclusion and commitment, and aggressive plans for organic growth through new product development and add-on acquisitions, the Company’s future is very bright which was extremely attractive to me.”

In mid-2019, Aspen was recapitalized by an affiliate of the New York based private equity firm, Cortec Group. Cortec invests in market-leading, middle-market specialty consumer, distribution, healthcare and specialty services and products businesses in partnership with owners and management teams who want to work with Cortec to drive growth and improve business fundamentals. “We remain pleased with our investment in Aspen Medical Products, which has performed well in a very difficult operating environment. Dan Williamson has been, and will continue to be, a great partner as he transitions to Board level involvement. We are excited to have someone with Jim Cloar’s experience and leadership capabilities as part of the team, and look forward to working with both of them to enable Aspen Medical Products to achieve continued success, while providing quality products to those who need them,” said Jeff Lipsitz, Co-President at Cortec.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X